- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01615471
Lose Now North Carolina Community Weight Loss Program (Lose Now NC)
Lose-Now-NC: Feasibility of a Large Group Format Community Weight Loss Program Coupled With Internet Support
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cancer is the leading cause of death in North Carolina (NC); over 17,400 deaths were attributable to cancer in 2009. Obesity is also a widespread problem; 65% of NC adults were overweight or obese in 2009. Obesity has been linked to risk of several cancers, most notably breast and colon cancer, and also to decreased survival rates. Thus, due to the prevalence and linkage of obesity to major cancers, helping adults to lose weight is necessary to reduce cancer burden statewide.
Fortunately, modest weight losses of only 5 to 10 percent of total body weight have been shown to improve health and are achievable with behavioral lifestyle modification programs, considered the "gold standard" intervention. To date, weight loss via lifestyle modification has been shown to be more effective, and more cost-effective, than pharmaceutical intervention for reducing risk of chronic disease. However, these "gold standard" programs are very time and resource intensive; involving weekly face-to-face (F2F) sessions with groups of 10-20 participants for, at minimum, 16-24 weeks followed by bi-weekly contacts for up to 2 years. To combat this problem investigators, including those from this investigative team, have explored using the Internet to deliver weight loss programs. Internet programs are modestly effective producing 4-7% weight loss (at 6 months) or roughly ½ of what intensive F2F programs can achieve. Internet programs that involve substantial human contact via e-mail produce the best outcomes, yet limit dissemination, and those that involve only automated feedback suffer from low utilization over time. What may be optimal is a hybrid model involving fewer F2F visits coupled with an Internet program. We are currently investigating an alternative F2F approach whereby participants attend F2F visits once per month, as phase 1 of a 6-step, stepped care approach to treating obesity (R01 HL084400). The initial results are promising; at 3 months weight losses did not differ significantly between the monthly F2F approach and weekly F2F approach (-15.23 + 10.22 lbs. weekly vs. -12.32 + 10.26 lbs. monthly; p>.05). While the monthly program is ¼ of the visits of the standard treatment approach, the group size of 20 still severely limits dissemination. Delivering this monthly F2F approach in much larger groups (approximately 200 or more), coupled with an Internet program between sessions, may represent an effective and disseminable approach for achieving weight loss in NC communities.
A standard behavioral intervention based on the DPP and Premier trials will be adapted for this protocol. Behavioral weight control approaches are founded on teaching skills and providing the support necessary to enable participants to adopt lower calorie diets (e.g., 1500-2000 kcals per day based on starting weight) and moderate physical activity (e.g., walking) to produce energy deficits necessary to produce modest weight losses of 1-2 lbs per week. Based on findings from the focus groups and review of study design and expectations from the funding source to conduct pilot research that will lead to future funding and publishable findings, the main intervention has been finalized (since initial IRB submission). The intervention will consist of randomization to either Large Group + Internet or Small Group + Internet interventions. The main difference between the two study groups will be the size of the monthly group sessions. The internet program delivered in between monthly group sessions will be identical. Group sessions will occur at the Nutrition Research Institute (NRI) on a monthly basis in months 1 - 4. The internet program will be used between group sessions. The monthly sessions will begin with an individual, private, weigh-in, followed by a group session. One treatment arm will have large group sessions with interactive features and audience participation. The large groups will be comprised of approx. 125 participants, last approximately 1 hour, and be facilitated by a weight loss expert (dietitian, psychologist, exercise physiologist). The other treatment arm will have small group sessions and will consist of approx. 25 participants and will follow traditional behavioral weight control group session protocol with facilitation by the above named-experts. Participants will be encouraged to enroll in the study with up to two friend or family member support partners who are also meet eligibility criteria. Support partners will be randomized to the same treatment arm. The F2F sessions are coupled with a comprehensive Internet program tested previously by Tate et al that provides the self-monitoring tools, tailored automated behavioral feedback, tailored lifestyle content (lessons) resources, and social support (e.g. online message board) that participants will be encouraged to use in between monthly sessions.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina at Chapel Hill
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18-65 years of age. Older adults have more medical co-morbidities; since this community program has minimal face-to-face supervision, individuals age >65 will be ineligible.
- Body mass index (BMI) greater than 25.0 kg/m2.
- Access to the internet on at least a weekly basis.
- Ability to read, write and speak English.
- Ability to attend 4 monthly group sessions and 2 assessment visits (baseline and follow-up) at the Nutrition Research Institute.
- Possession and usage of an internet e-mail address or willingness to sign up for a free email account (e.g., gmail)
Exclusion Criteria:
- Pregnancy during the previous 3 months, or planned pregnancy in the folliowing 6 month (study period including assessments and treatment).
- Current participation in another weight loss study or program (including weight loss medication) and unwilling to discontinue participation for the duration of the study.
- Insulin treatment for diabetes mellitus.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Large Group
In person group sessions in large group format (up to 125 others)
|
Monthly in-person group sessions with an companion internet weight loss intervention
|
|
Active Comparator: Small group
Small group in person sessions (up to 25 other participants)
|
Monthly in-person group sessions with an companion internet weight loss intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight change
Time Frame: 4 months
|
Change in weight from baseline to 4 months
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diet
Time Frame: 4 months
|
Change in diet as assessed by ASA 24
|
4 months
|
|
Physical Activity
Time Frame: 4 months
|
Change in Physical Activity as assessed by Paffenbarger Exercise Questionnaire
|
4 months
|
|
Lipids
Time Frame: 4 months
|
Change in lipids
|
4 months
|
|
Hemoglobin A1c
Time Frame: 4 months
|
Change in HbA1c
|
4 months
|
|
Blood Pressure
Time Frame: Baseline to 4 months
|
Change in Blood Pressure from Baseline to 4 months
|
Baseline to 4 months
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LNNC2012
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on Group weight loss with companion internet
-
The Miriam HospitalCompleted
-
National Institute of Diabetes and Digestive and...Completed
-
California Polytechnic State University-San Luis...University of North Carolina, Chapel HillCompleted
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
Kaiser PermanenteUniversity of Minnesota; Oregon Research InstituteCompleted
-
University of HelsinkiFinnish Medical FoundationCompleted
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Menopause | Sarcopenia | OsteoporosisUnited States
-
VA Office of Research and DevelopmentCompleted